KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients (Q37313183)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 2008
edit
Language Label Description Also known as
English
KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients
scientific article published on October 2008

    Statements

    KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients (English)
    1 October 2008
    2140-2155

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit